Today: 9 April 2026
GOOG stock price rises as EU opens Google data-sharing proceedings ahead of Alphabet earnings
27 January 2026
2 mins read

GOOG stock price rises as EU opens Google data-sharing proceedings ahead of Alphabet earnings

NEW YORK, Jan 27, 2026, 10:43 EST — Regular session

Alphabet’s non-voting Class C shares (GOOG) ticked up roughly 1.0% to $336.97 Tuesday morning, following a $333.59 close the day before. The European Commission announced it has launched proceedings under the Digital Markets Act to steer Google on meeting interoperability and search-data sharing requirements. Digital Markets Act (DMA)

The timing is just before Alphabet’s quarterly earnings, with investors eager to see if hefty AI investments will drive lasting growth. According to Reuters, Alphabet, Microsoft, Meta, and Amazon are set to boost AI spending by about 30% this year, pushing total investment past $500 billion and intensifying focus on profit margins and cash flow. “Alphabet has the upper hand in the AI race,” said David Wagner, head of equities at Aptus Capital Advisors. Reuters

EU tech chief Henna Virkkunen said the DMA proceedings aim to ensure Google grants the same access to search data and Android to third-party search engines and AI providers as it does to its own services, including Google Search and Gemini. Clare Kelly, Google’s senior competition counsel, described Android as “open by design” but cautioned that rules shaped by “competitor grievances” risk harming user privacy, security, and innovation. EU antitrust chief Teresa Ribera emphasized the objective is a “level playing field,” not one skewed in favor of “the largest few.” Reuters

Tech stocks climbed in early U.S. trade, led by the Invesco QQQ ETF, which added roughly 0.8%. The S&P 500 ETF nudged up slightly, but the Dow ETF dipped. Microsoft rose around 1.3%, Amazon jumped about 1.5%, and Meta slipped a bit.

Regulatory troubles caught up with Google this week in court. The company agreed to a $68 million settlement over a class action alleging its Google Assistant recorded users after so-called “false accepts” — when it mistakenly heard its wake words — to better target ads, court documents show. The deal was filed in federal court in San Jose, California, and now awaits approval from U.S. District Judge Beth Labson Freeman. Google denied any wrongdoing. Reuters

The EU process is a specification proceeding — a tool Brussels uses to clarify how a company must comply with DMA rules — not a new antitrust case. Officials in the EU say the process needs to wrap up within six months. AP News

Alphabet will report its fourth-quarter results in a call set for Feb. 4 at 1:30 p.m. Pacific time, the company’s investor relations calendar shows. abc.xyz

Analysts are forecasting Alphabet’s Q4 revenue to exceed $100 billion, according to consensus estimates highlighted by Investors Business Daily. The outlet also noted rising institutional interest in the stock ahead of the earnings release. Investors

The build-up to Big Tech earnings has been anything but smooth, with investors cautious that the AI trade might be overhyped for now. According to Investopedia, the “Magnificent 7” kicked off 2026 unevenly, with more focus shifting to their upcoming earnings guidance. Investopedia

Alphabet announced it will release its earnings on Feb. 4 before the conference call and provide a live webcast, with a replay to follow. For GOOG shareholders, that report is the next major catalyst. abc.xyz

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
USA Rare Earth stock whipsaws as $1.6 billion CHIPS-backed plan meets dilution worry
Previous Story

USA Rare Earth stock whipsaws as $1.6 billion CHIPS-backed plan meets dilution worry

Netflix stock dips as UK antitrust pressure mounts on Warner bid and Senate hearing nears
Next Story

Netflix stock dips as UK antitrust pressure mounts on Warner bid and Senate hearing nears

Go toTop